Why does null hypothesis testing matter for target validation in microfluidic CODES?

Scientific Value: Enables interrogation of therapeutic hypotheses through electronic sizing and spatial tracking of particles in multiplexed channels.
Operational Value: Supports biological de-risking by providing direct electronic readouts of particle distribution without microscopy.

Null hypothesis testing helps determine whether observed particle size distributions across channels are statistically significant, supporting confident target validation by distinguishing true biological signals from noise in multiplexed electronic readouts.

How does independent variable isolation fit the discovery pipeline in microfluidic CODES?

Isolating variables such as flow rate, particle concentration, and channel geometry enables precise attribution of electronic signal changes to specific biological conditions, improving reproducibility in early discovery workflows.

What quantitative dependent variable measurements enable microfluidic CODES implementation?

Dependent variables include impedance modulation amplitude, signal duration, and timing relative to flow, which are used to calculate particle size, location, and transit time through multiplexed channels.

Why do replication requirements matter for cross-functional collaboration in microfluidic CODES?

Replication ensures that electronic signal patterns and decoding accuracy are consistent across operators, labs, and fabrication batches, enabling reliable data sharing between discovery, assay development, and translational teams.

What statistical analysis capabilities are required before implementing microfluidic CODES?

Implementation requires capabilities in signal correlation, autocorrelation peak detection, iterative signal separation, and least-squares optimization to reconstruct individual sensor outputs from multiplexed waveforms.